$1.7M Bet On Erasca? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Author: Avi Kapoor | December 07, 2023 09:33am

The Dow Jones closed lower by around 70 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Erasca

• The Trade: Erasca, Inc. (NASDAQ:ERAS) Chairman and CEO Jonathan Lim acquired a total of 1,000,000 shares an average price of $1.70. To acquire these shares, it cost around $1.7 million.
• What’s Happening: On Nov. 9, Erasca posted a narrower-than-expected quarterly loss.
• What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Sonder Holdings

• The Trade: Sonder Holdings Inc. (NASDAQ:SOND) Chief Accounting Officer Adam Bowen acquired a total of 10,000 shares at an average price of $2.89. To acquire these shares, it cost around 28,900.
• What’s Happening: On Nov. 14, Sonder Holdings posted a narrower third-quarter loss.
• What Sonder Holdings Does: Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East.

Check This Out: Top 5 Industrials Stocks That May Collapse This Month

Aspira Women's Health

• The Trade: Aspira Women's Health Inc. (NASDAQ:AWH) President and CEO Nicole Sandford acquired a total of 5,000 shares at an average price of $3.36. The insider spent around $16,800 to buy those shares.
• What’s Happening: On Nov. 13, Aspira Womens Health posted a narrower-than-expected quarterly loss.
• What Aspira Women's Health Does: Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases.

Charles & Colvard

• The Trade: Charles & Colvard, Ltd. (NASDAQ:CTHR) President and CEO Don Oconnell acquired a total of 60,986 shares at an average price of $0.44. The insider spent around $26,834 to buy those shares.
• What’s Happening: On Nov. 9, Charles & Colvard posted a wider quarterly loss.
• What Charles & Colvard Does: Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market.

Don’t forget to check out our premarket coverage here

Posted In: AWH CTHR ERAS SOND